MedPath

To find out which drug (dexmedetomidine or midazolam) will provide better sedation and patient satisfaction in deviated nasal septum corrective surgery under local anaesthesia.

Not Applicable
Completed
Conditions
Health Condition 1: null- Patients diagnosed as deviated nasal septum posted for elective septoplasty
Registration Number
CTRI/2016/08/007182
Lead Sponsor
o
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

60 ASA physical status I-II interested patients, aged between 18 and 50 years undergoing elective septoplasty under local anaesthesia were included.

Exclusion Criteria

We excluded Mallampati class 3 & 4, obese, obstructive sleep apnoea, difficult airway patients, patients with liver, cardiovascular, haematological, psychiatric disorders, known hypersensitivity to dexmedetomedine or midazolam, substance abusers, hypertensives (SBP >150 mmHg, DBP >90 mmHg), patients taking beta blocker therapy, guanethedine, cardiac glycoside.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sedation efficacy comparison <br/ ><br>patient satisfaction score <br/ ><br>Timepoint: assessment of sedation every 10 minutes using Ramsay sedation score <br/ ><br>patient satisfaction assessment <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Heart rate <br/ ><br>Systolic blood pressure <br/ ><br>Diastolic blood pressure <br/ ><br>Mean arterial pressure <br/ ><br>Oxygen saturation <br/ ><br>Respiratory rate <br/ ><br>Rescue fentanyl requirement <br/ ><br>Surgeon satisfaction scoreTimepoint: assessment done every 10 minutes during procedure <br/ ><br>monitored 2 hours in recovery room post operatively
© Copyright 2025. All Rights Reserved by MedPath